3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma, Ewing
2
Sarcoma
2
Osteosarcoma
2
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Malignant mesenchymal tumor
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Hodgkin Disease
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Fibrosarcoma
1
Disorders of Sex Development
1
Dermatofibrosarcoma
1
Chondrosarcoma, Extraskeletal Myxoid
1
Interventions
pembrolizumab
55
Carboplatin
55
Pemetrexed
47
Cisplatin
37
Paclitaxel
21
Nivolumab
20
Docetaxel
19
durvalumab
18
osimertinib
14
Gemcitabine
14
Cetuximab
14
130-nm albumin-bound paclitaxel
14
atezolizumab
12
Specimen Handling
12
Magnetic Resonance Spectroscopy
12
amivantamab
10
Radiotherapy
8
lazertinib
7
Taxes
7
Radiosurgery
7
alectinib
6
Ramucirumab
6
Observation
6
Ipilimumab
6
Bevacizumab
6
cemiplimab
5
Leucovorin
5
Fluorouracil
5
zimberelimab
4
entrectinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Non-Small-Cell Lung
×
Ifosfamide
×
30 days
×
Clear all
No trials found.